Introduction
The spastic paretic muscle is subject to structural changes compared to healthy skeletal muscles. These changes are independent from the initial etiology of the neurological lesion. The literature describes an increased variability of the size and type of muscle fibers, decreased numbers of sarcomeres, proliferation of the extracellular matrix (ECM) with an increased collagen concentration [1, 2] . When the first motor neuron is affected, muscle retraction can get settled under the influence of two main factors. The disuse of the paretic muscle or ''functional immobilization'', which initiates muscle atrophy and reduces the number of sarcomeres by a disequilibrium of the protein-proteolysis synthesis balance in favor of the proteolysis [3, 4] . Chronic muscle hyperactivity maintains the muscle in a short position, reducing the longitudinal tension [5] . Thus, the shortening of the muscle fibers and accumulation of conjunctive tissue are responsible of these changes in biomechanical viscoelastic properties of the muscles, with a decreased passive extension capacity [3] [4] [5] [6] .
Muscle changes contribute to functional impairments. Gait speed and step length have been significantly correlated to passive mechanical properties of the plantar flexor muscles, determined by the measure of the passive torque/joint angle ratio of the talocrural joint [7] . For Dietz and Sinkjaer, the spastic muscle at rest is Methods: We present a literature review abiding by the PRISMA statement guidelines. The purpose was to explore the structural and passive biomechanical muscle properties after botulinum toxin type A injections in healthy and spastic limb muscles, on animals and humans, as well as methods for evaluating these properties. We searched the PubMed and Cochrane Library databases using the following keywords: ''Botulinum toxin'' AND (''muscle structure'' OR ''muscle atrophy'') and, ''Botulinum toxin'' AND ''muscle elasticity''. Results: From the 228 initially identified articles, 21 articles were included. Histological analyses were performed, especially on animals. A neurogenic atrophy systematically occurred. In humans, one year after a single injection, the histological recovery remained incomplete. Furthermore, 2D ultrasound analyses showed a reduction of the gastrocnemius thickness and pennation angle. MRI volumetric analysis evidenced muscular atrophy six months or one year after a single injection. Passive muscle stiffness depends on these structural changes. On the short term, the biomechanical analysis showed an elastic modulus increase in animals whereas no change was recorded in humans. On the short term, ultrasound elastography imaging showed a decreased elastic modulus. Discussion: To date, few data are available, but all show a structural and mechanical muscle impact post injections, specifically muscle atrophy which can linger over time. Further studies are necessary to validate this element, and the possibility of change must be taken into account particularly with repeated injections. Thus, in clinical practice, 2D ultrasound and ultrasound elastography are two noninvasive techniques that will help physicians to develop an efficient long term monitoring.
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submitted to an overexcitability of the alpha motor neuron (presynaptic inhibition and increased activity of type Ia ascending fibers) with little changes during voluntary contractions. Thus, hyperreflexia is hardly involved in pathologic spastic movements [6] . Injections of botulinum toxin type A (BoNtA) are a first-line therapeutic method to treat focal spasticity [8] ). Their action is triggered by the fixation on the SNARE proteins and inhibited release of acetylcholine (ACh) from the presynaptic terminals. The therapeutic objective is to decrease reflex muscle overactivity and fight muscle hypertonia. The functional benefit will affect gait patterns and movement amplitude [9] [10] [11] [12] . However, the impact of BoNtA injections on muscle structure and the stretching capacity of muscle tissue have rarely been reported in the literature. The challenge is to differentiate the consequences related to spastic paresis from those linked to the injections of botulinum toxin. We propose a review of the literature with the following objectives:
analyze changes in the structure and stiffness of muscle tissue described after an injection of botulinum toxin in one muscle of the limbs; discuss the evaluation methods used.
Methodology
A systematic review of the literature was conducted abiding by the PRISMA recommendations (www.prisma-statement.org). We searched the Pubmed and Cochrane Library databases, using the following keywords ''Botulinum toxin'' AND (''muscle structure'' OR ''muscle atrophy'') and, ''Botulinum toxin'' AND ''muscle elasticity''. Articles stemming from this research were independently put aside by 2 authors (LM and BP) and were then evaluated. Articles were kept if they met the following criteria:
the study focused on the analysis of a striated skeletal muscle of the limbs, paretic spastic or healthy (to differentiate changes related to spastic paresis), in men and humans; the study analyzed the consequences of injections of botulinum toxin on muscle structure and/or muscle tissue stiffness; evaluation methods in the fields of histological, mechanical and medical imaging analyses were described; the full manuscripts were published in English between 1990 and October 2014. References of the articles included were used to eventually complete the selection. In case of disagreement, a decision was taken after further discussion.
The methodological quality of the articles was evaluated using a specific scale developed based on the STROBE (Strengthening the Reporting of Observational studies in Epidemiology) principles [13] . Each item was categorized, and the maximum global score is 28 ( Table 1 ).
Results

Selection of the studies
In all, 228 articles were initially identified ( Fig. 1 ). Thirty-two articles were deemed relevant after reading the titles and abstracts. Twenty-one were included in the review (11 were excluded because they did not meet the selection criteria). Fourteen studies focused on the structural analysis, 3 studies on muscle stiffness analysis and 4 studies on both structure and stiffness analysis. Overall, there were very few studies, with often a restricted population sample (from 1 to 56 patients in men) and various exploration methods.
Quality of the reviewed articles
The quality of the reviewed articles is summed up in Table 2 . It is highly variable. Most studies were prospective ones, except for 2 case studies [14, 15] and a retrospective study [16] . The descriptive quality of the experimental protocol, results as well as their interpretation and conclusion was adequate in most studies. The reproducibility of evaluation method was rarely described. No study proposed sample size calculations. The followup duration was quite short in most studies ( 3 months). (Table 3) The methodological variability among the small number of studies, made it mandatory to conduct an evaluation based on changes in muscle structure and passive mechanical properties and according to the exploration techniques used.
Literature analysis
Structural changes
Analysis via muscle samples in animals, muscle mass analysis based on post-mortem dissection reports post-injection atrophy [17] [18] [19] [20] [21] [22] [23] [24] . It occurs from 1 week [22, 24] to 4 months [24] after one injection, with a dose effect. A dose twice as important (6 U Botox/ kg versus 3 U Botox/kg) reduces the delay of onset to one week (versus 4) [23] . After one single injection, the intensity of the loss in muscle mass varied from 30 to 60% (dose effects, muscles and animal injected) according to the various studies [17] [18] [19] [20] [21] [22] [23] [24] . The recovery was highlighted at 4 months [23] or 1 year [24] . The recovery was incomplete, in the range of 90% recovery of the initial muscle mass. Following repeated monthly injections, Fortuna et al. [19] brought up the possibility of a ceiling effect of the atrophy after the third injection, around 60%. At one year, results showed that repeating an injection at 6 months majors muscle atrophy and in a dose-dependent manner.
Histological slides were used to analyze muscle fibers [17-19, 21,22,24,25] , via optical (OM) [17] and electronic microscopy (EM) [22, 24] . A precise analysis of contractile proteins [19, 21] (automated measurement technique: Mat Lab Program) [19] was conducted which also included the composition of myosin heavy chains, titin molecular mass (gel electrophoresis), extracellular matrix and amount of collagen (hydroxyproline assay) [25] . After one single injection, the structure of the sarcomeres is altered with a misalignment of Z-lines. The initial structure was restituted at 6 months [24] . Changes in contractile proteins were observed. Table 1 Quality analysis form used in the systematic review.
Q1
Is there in the abstract an explanation of what was done and found? Q2
Is the scientific context clearly explained? Q3
Are the objectives clearly stated? Q4
Is the sampling size indicated? Q5
If yes, is the sampling size statistically justified? Q6
Are the characteristics of the subjects (height, weight, sex, healthy or pathologic subject) described? Q7
What is the design of the study? (0: retrospective study; 1: case study; 2: prospective study). Q8
Is there a control group? (0: no, 1: contralateral member or nonrandomized control group, 2: randomized control group). Q9
How long is the follow up? (0: 1month; 1 6 month; 2 ! 1 year) Q10
Is the reliability of the evaluation method clearly described? Q11
Are the results interpretable? Q12
Are the limitations of the study discussed? Q13
Is the conclusion clearly stated? 0: no description; 1: limited description; 2: good description. After one injection, the percentage of fast twitch Type IIb fibers decreases in favor of intermediate Type IIa fibers and slow twitch Type I fibers, in the gastrocnemius muscles [18, 21] and the tibialis anterior muscle [25] . In monthly injections, the quantity of myosin heavy chains (MHC) decreases after the 3rd month (in the range of 70% of surface MHC on the rectus femorus and vastus lateralis, vs. > 90% before the injection as evidenced on histological slides) [19] . It decreases again down to about 40% at 6 months, on the vastus lateralis [19] . Finally, 1 month after one injection, the amount of collagen in the muscle increases (in the order of 40%), as well as the expression of the titin protein, the most abundant elastic protein in the muscle fiber [21, 25] .
In humans, only the work of Schroeder et al. [26] reported histological data based on muscle biopsies. One year after one single injection of 75 U Xeomin in the lateral gastrocnemius muscle, the authors reported changes in the muscle structure [26] . In optical microscopy, the surface of muscle fibers is reduced by 24%, muscle fibers have an angular shape [27] , and the atrophy is compensated by a process of fibrosis. Under electronic microscopy, authors evidenced a negative progression of neuromuscular junctions, with an increase of the space located between nerve endings and motor plates. A decrease in the number of crests of the synaptic folds, where RnAch accumulates, was noted.
Medical imaging analysis
2D ultrasound was used in 4 studies [15, [28] [29] [30] , 2 in children with cerebral palsy [15, 28] and 2 in post-stroke hemiplegic patients [29, 30] . This technique allows a reproducible evaluation of the muscle by measuring muscle thickness, a section of muscle surface and the pennation angle [21] . Tok et al. [30] and Picelli et al. [29] respectively reported results on 56 and 26 hemiplegic patients (chronic phase > 1 year) by making a comparison with the contralateral limb which did not receive any injections. The ultrasound analysis was conducted 1 to 2 months after a single injection in the gastrocnemius muscles with commonly-used doses. Tok et al. excluded patients who benefited from injections within the previous year [30] . They reported a decrease in muscle thickness and for the pennation angle as well as an increase in the muscle fascicle length [30] . Picelli et al. [29] did not report any changes in muscle echo intensity after injection. They considered that the efficacy of the injections was diminished in spastic muscles with increased echo intensity, evidencing muscular degeneration (Heckmatt III-IV scale). Boyaci et al. [28] in 16 children with cerebral palsy and Kwon et al. [15] on one single patient, reported increased medial gastrocnemius thickness 4 weeks after one single injection (in the range of 2 mm). However, the injection was performed with lower doses than those usually used and children had previously benefited from an intensive rehabilitation program including muscle strengthening.
Magnetic Resonance Imaging (MRI) helps refine the level of muscle atrophy by quantifying muscle volume and analyzing the signal of fatty tissue involution. According to Schroeder et al. [26] , Van Campenhout et al. [33] , and William et al. [34] , after a single injection of botulinum toxin, muscle atrophy sets in (from 4 to 30%). This atrophy lingers from 6 months to 1 year after an injection in healthy subjects [26] , and in diplegic children [33] . For Van Campenhout et al., the proximal injection of the psoas fascia of the iliopsoas muscle induces a 20% reduction in muscle volume at 2 months [33] whereas, a distal injection was not correlated to atrophy.
Changes in the passive mechanical properties of the muscle
We looked for changes in the passive stiffness of the muscular system (ratio between the variation in muscle length and the stretching force). It is most often quantified based on Young's modulus (E) determined by the ratio stress/strain (E = s/e, in MPa with s = stress in MPa and e: L -L0/L0 = strain).
Two studies on animal models reported an in-vitro analysis on a healthy muscle [25, 35] . The analysis was performed at the scale of the muscle (gastrocnemius, calcaneal tendon, calcaneus) related to its lever arm: [35] , or at the scale of a fiber bundle of the anterior tibialis muscle [25] . Calculation of the elastic modulus was performed by creating stretching and recording the changes in the length of the muscle-tendon unit or muscle fibers and passive strain necessary for displacement. Haubruck et al. [35] , showed that 8 days after an injection there was a significant reduction of stiffness in the range of 30%. For Thacker et al. [25] , one month after an injection on a single muscle fiber, the elastic modulus decreased by 15% and so did the muscle fiber. Furthermore, the passive elastic modulus of fiber bundles doubled after one injection. The variable difference between a unique muscle fiber and fiber bundles can be explained by the accumulation of intermyofibrillar collagen.
Five studies analyzed the viscoelastic properties of spastic muscles, including 4 studies on children with cerebral palsy after injection of BoNtA [14, 15, 28, 36, 37] . Alhusaini et al. [36] assessed the stiffness of the triceps surae-calcaneal tendon-talocrural joint unit, by measuring the passive torque during passive rhythmic rotation of the ankle at slow speed (608/s). They did not evidence any significant changes in stiffness 6 weeks post injection. The other studies used elastography imaging [14, 15, 28, 37] . Its principle resides in measuring the strain induced by the compression of biological tissues. The Shear Wave Elastography (SWE) technique implies the production of shear waves through the tissues, thus generating a strain on the tissue. The elasticity of muscle tissue is represented by color mapping [14, 15, 28, 37] and quantified by measuring either the strain ratio or the elastic modulus. When the elastic modulus is greater, the muscle becomes stiffer. Four weeks after an injection in the medial gastrocnemius muscle, there is a decrease in muscle stiffness related to a reduction of spasticity [15, 28, 37] . Studies by Boyaci et al. and Park et al. [28, 37] associate the effect of the botulinum toxin injection to an intensive rehabilitation program (stretching and muscle strengthening exercises).
The study of muscle stiffness is quite complex. It must be in accordance with the system of analysis used: muscle fiber, muscle, muscle-tendon unit, muscle-tendon-joint unit, and the evaluation method. In children with cerebral palsy, a few weeks after an injection of botulinum toxin, the stiffness of the system: triceps surae-calcaneal tendon-talocrural joint, measured using the ratio passive torque/angle joint was not modified [36] . However, the stiffness of the medial gastrocnemius muscle, measured via SWE, had decreased [15, 28, 37] .
Discussion
Looking for structural and mechanical changes in the spastic muscle after injection of botulinum toxin has rarely been reported in the literature, in humans and animals alike, and the few studies that did focus on this topic had very different analytic methods. However, the stakes of such changes are very important: being aware, on a structural level, of the muscular deterioration induced by botulinum toxin; deducing the changes in tissue stiffness in regards to the system of analysis chosen; and implementing in humans reliable evaluation modalities for both muscle structure and stiffness.
In fact, on a structural level, we can report that in animals, one single injection of BoNtA induces muscle atrophy that lingers for at least one year, with loss of muscle mass. Repeated injections major this atrophy and increase its duration with a dose-effect and frequency of the injections [19, 24] . The transition of myosin heavy chains (MHC) towards slower phenotypes [18, 21, 25] , might change the conditions of the muscle fibers' dynamic contraction [38] . For gastrocnemius muscles that have a faster contraction profile and are often injected, this decrease in contractile proteins induces a decrease in the maximum strength, lingering more than one month post injection, it is proportional to the dose injected [18, 39] and has an impact on the shortening speed of muscle fibers. In humans, these data cannot be fully extrapolated. Only the study by Schroeder et al., in healthy lateral gastrocnemius muscles, unveils classic signs of neurogenic atrophy [26] .
Based on a non-invasive exploration via 2D ultrasound, the measurements of muscle thickness and pennation angle at the level of the gastrocnemius muscles are reproducible at rest in healthy subjects, children [40] , older adults [31] and in post-stroke hemiplegic patients [32] . This requires abiding by a standardized procedure for the location of ultrasound landmark measurements. However, the articles in this literature review presenting the architectural consequences on muscles of botulinum toxin injections did not describe any standardized measurement procedures [29, 30] . The following settings and procedure must be respected to meet reproducibility and sensitivity criteria: 2D ultrasound machine with a probe adapted for muscle analysis (linear probe with a 6-15 Hz frequency); experienced operator with a solid knowledge of muscle anatomy, including the fascial organization of muscles to evaluate changes in muscle architecture via ultrasound; finally a validated institutional reproducible procedure of ultrasound anatomical landmarks and measurements done. Furthermore, it has been reported in 2D ultrasound that when the muscle has a high signal intensity and a loss of fasciclelike organization of the muscles fibers, there is a greater fatty infiltration muscle fibrosis [41] . This latter evaluation is strictly qualitative and depends on a wide inter-individual echogenicity, especially according to the thickness of the subcutaneous fat pedicle. The use of MRI in muscle analysis has rarely been reported in this context of post botulinum toxin injection [26, 33, 34] , whereas the technique allows an interesting analysis of the denervated muscle [42] .
Muscle atrophy has been evidenced, but its intensity, duration, reversible nature, or even its compensation by other muscles remains unknown. According to the study by William et al. [34] , among a population of children with cerebral palsy, the volume of the non-injected soleus muscle was increased (4%) suggesting a compensating mechanism within the triceps surae muscle.
Studies on musculoskeletal stiffness after injection of botulinum toxin in humans and animals were conducted with very different protocols, all using variable criteria. Thus, the resulting data are very heterogeneous and can sometimes seem contradictory. There has not been an assessment of the consequences of injections on muscle stiffness beyond 6 weeks. However, patients who benefit from a treatment with botulinum toxin receive repeated injections several times a year, for a long period of time. The concept of muscle stiffness is related to its behavior as a viscoelastic environment. In fact, in the case of the spastic muscle, stiffness can be refined and assessed according to the analytic approach. In a clinical approach, it is the limitation of the joint range of movement when the muscle is subjected to passive stretching (stretching hyperreflexia or tendon-muscle retraction). In a biomechanical approach, the study refers to a model analyzing the elastic structures of the muscle-tendon system, such as the biomechanical muscle model of Hill [43] that takes into account the contractile element (CE) and two non-linear spring elements, one in series (SE) and another in parallel (PE). The latter yields information on viscoelastic properties at rest. In humans, the evaluation of passive muscle stiffness is possible on a ''relatively'' isolated muscle using passive movements [44] . The relationship passive torque/joint angle is based on the measurement of the force exerted to mobilize the joint under different angles. This relationship is not a linear one and maximum torque can vary depending on the given joint [45] due to the variable quantity of conjunctive tissue in the muscle groups. This method remains the gold standard, it was initially used to measure the consequences of muscle lengthening by successive plaster casting [46] on muscle and tendons. Nevertheless, and to our knowledge, the only study [36] conducted after an injection of botulinum toxin in spastic muscles, did not find any decrease in passive stiffness for the triceps surae-calcaneus-talocrural joint, 6 weeks after the injection. However, in animal models, the passive elasticity module of muscle fascicles increases 1 month post-injection [25] . No potential correlation with the increased collagen and structure protein regulating the viscoelastic properties of muscles, such as the titin protein, was demonstrated. Following a more mechanical approach, the ''stiffness'' of muscle tissue, as a viscoelastic material, depends on the intrinsic muscle structure and its contractile status at rest. It can be analyzed via elastography imaging. The use of this non-invasive method, in real time, and without any involvement of the patient, seems adapted to the evaluation and follow-up of neuromuscular pathologies, especially spasticity and its local treatment. The reproducibility of this technique still needs to be analyzed in pathologic populations according to a well-determined procedure: experimented operator, standardized mapping of an echo-anatomical area, technical condition (control of the exerted pressure).
Conclusion
Even though the use of BoNtA is recommended in the literature [47] [48] [49] , and its functional benefits have been acknowledged [50] [51] [52] , this review of the literature demonstrates that these injections lead to structural changes in the muscle: lingering atrophy, with a remodeling of the muscle contractile proteins, which is probably not completely reversible; and changes in muscle elasticity. It seems essential, in light of the repeated injections of BoNtA in one single individual, to conduct further studies on muscular changes induced by BoNtA injections. Specifically, it requires the implementation of validated and non invasive exploration procedures, at rest and in motion. The 2D ultrasound imaging, coupled with a validated measurement procedure via elastography imaging, appears to be the best technique to meet this requirement. The challenge being to better define the indications for injections and associated treatments such as stretching, posture, lengthening casts, muscle strengthening and in some specific cases, surgical management.
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